Microdosing: The Phenomenon, Research Results, and Startling Surprises
James Fadiman, Ph.D., and Sophia Korb, Ph.D.
Friday, April 21, 2017 • 3:00 PM - 4:00 PM • Grand Ballroom
In this presentation, we will review how microdosing emerged, how we became involved in the research, and our current observational research protocol. We will report on a wide variety of presenting needs, conditions, demographics, and experiences from several hundred people’s experiences from over a dozen countries, all of whom followed a standardized protocol. We will present our results, showing evidence that microdosing can favorably affect people diagnosed with a number of serious and persistent mental illnesses (including those labeled as "treatment-resistant") as well as some specific physical conditions. People microdosing for both enhanced wellness and medical reasons report enhanced creativity, improved relationships and better physical skills. Many of our participants were able to titrate and even cease their use of conventional pharmaceuticals. We will consider the value and the limitations of our own methods, as well as conditions that may be contraindicated for microdosing. We will discuss how we supported hospital and university-based studies as well as underground research teams. We will also reveal some surprising and unexpected results.
James Fadiman, Ph.D., did his undergraduate work at Harvard and his graduate work at Stanford, doing research with the Harvard Group, the West Coast Research Group in Menlo Park, and Ken Kesey. He is the author of The Psychedelic Explorer’s Guide.